Thermo Fisher Scientific Inc. closed 16.60% short of its 52-week high of $627.88, which the company achieved on September 10th.

Citi lowered the firm’s price target on Thermo Fisher (TMO) to $570 from $650 and keeps a Neutral rating on the shares. The firm updated models ...

Well, welcome to the 45th Annual TD Cowen Healthcare Conference. I'm Dan Brennan, follow Tools and Diagnostics. Really pleased to be joined on stage here with Marc Casper, Chairman and President of ...

Valued at a market cap of $200 billion, Thermo Fisher Scientific Inc. (TMO) is a Massachusetts-based powerhouse in scientific ...

This fundamental study reports the effects of the psychedelic drug psilocin on iPSC-derived human cortical neurons, analyzing different aspects of structural and functional neuronal plasticity. The ...

DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...

Los Angeles County Science and Engineering Fair will welcome more than 1,400 students Sunday, March 9, and Monday, March 10, ...

Biocon Academy conducts 9th Graduation Day, 165 students graduated from 5 specialized programmes: Our Bureau, Bengaluru Tuesday, March 4, 2025, 14:45 Hrs [IST] Biocon Academy, a C ...

Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 ...

Jabil Inc. (NYSE: JBL) has released its fiscal year 2024 Sustainability Progress Report, detailing the strides the company ...

The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...

The microbial fermentation technology market is experiencing significant growth, fueled by the increasing incidence of chronic diseases like cancer a ...